Literature DB >> 30637643

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.

Zhimin Hu1, Juling Zhang2, Zhongju Chen3, Zhengjiang Jin4, Pei Leng5, Junying Zhou6, Xiaofang Xie7.   

Abstract

In this multicenter study, we compared the performance of the Bruker Biotyper MS system and VITEK 2 YST systems for invasive yeast identification, investigated the distribution of isolated species, and evaluated the antifungal susceptibility profiles of Candida albicans, Candida parapsilosis, and Candida tropicalis. In cases of discrepant results lack of identification with either method, molecular identification techniques were employed. We tested 216 clinical isolates, and concordance between the two methods was observed for 192/216 isolates (88.9%). For five unidentified strains (2.3%), an internal transcribed spacer (ITS) sequencing approach was used. In brief, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS) provided short turnaround times and more reliable results than those of Vitek 2 YST. In Wuhan, C. albicans, C. parapsilosis, Candida glabrata, and C. tropicalis were the most common pathogens (93.0%) in patients with candidemia. Cryptococcus neoformans was mainly detected in cerebrospinal fluid samples (88.9%). Trichosporon asahii were all isolated from drainage fluids in the Surgery. Candida albicans was clearly susceptible to azoles, while C. parapsilosis and C. tropicalis displayed differences in susceptibility to azoles. Our findings provide a basis for the practical application of MALDI-ToF MS for identification and for the use of ATB FUNGUS 3 to characterize the susceptibility of Candida spp., thereby providing significant data for therapeutic decisions.

Entities:  

Keywords:  Antifungal susceptibility test; Candida; Identification; Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; Yeast

Mesh:

Substances:

Year:  2018        PMID: 30637643      PMCID: PMC6863291          DOI: 10.1007/s42770-018-0027-0

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  47 in total

Review 1.  British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Authors:  David W Denning; Christopher C Kibbler; Rosemary A Barnes
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

Review 2.  Emerging opportunistic yeast infections.

Authors:  Marisa H Miceli; José A Díaz; Samuel A Lee
Journal:  Lancet Infect Dis       Date:  2011-02       Impact factor: 25.071

3.  The changing epidemiology of healthcare-associated candidemia over three decades.

Authors:  Daniel Diekema; Sophie Arbefeville; Linda Boyken; Jennifer Kroeger; Michael Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  2012-05       Impact factor: 2.803

4.  Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Authors:  Joseph Meletiadis; Michael Arabatzis; Maria Bompola; Konstantinos Tsiveriotis; Stavroula Hini; Efthymia Petinaki; Aristea Velegraki; Loukia Zerva
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

Review 5.  MALDI-TOF-MS-based species identification and typing approaches in medical mycology.

Authors:  Oliver Bader
Journal:  Proteomics       Date:  2013-01-21       Impact factor: 3.984

6.  Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  O Bader; M Weig; L Taverne-Ghadwal; R Lugert; U Gross; M Kuhns
Journal:  Clin Microbiol Infect       Date:  2010-12-03       Impact factor: 8.067

7.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates.

Authors:  G Marklein; M Josten; U Klanke; E Müller; R Horré; T Maier; T Wenzel; M Kostrzewa; G Bierbaum; A Hoerauf; H-G Sahl
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

8.  Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; J F Meis; I M Gould; W Fu; A L Colombo; E Rodriguez-Noriega
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

9.  A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory.

Authors:  Simon Lévesque; Philippe J Dufresne; Hafid Soualhine; Marc-Christian Domingo; Sadjia Bekal; Brigitte Lefebvre; Cécile Tremblay
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

10.  Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study.

Authors:  Ding Li; Rui Xia; Qing Zhang; Changsen Bai; Zheng Li; Peng Zhang
Journal:  BMC Infect Dis       Date:  2017-08-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.